Determining Value
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
Diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’ decisions on interventions and to clarify how their behaviour may…
Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
1 October 2010
Ten member companies of the EFPIA HTA Task Force commissioned OHE consulting to provide research, data and analysis that would enable EFPIA both to support and…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how…
Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
1 October 2009
In this Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. …
The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?
1 January 2007
For the purposes of defining the economic and policy issues facing the vaccine industry, the comments made here are based largely on the experience in the…
Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
1 May 1997
Getting value for money from the use of pharmaceuticals is crucial for the NHS. This publication explores the role for guidelines in generating good quality value…
The Economic Impact of Medicines
9 January 1990
The objective of medical care is to improve people’s health. This includes avoiding illness whenever possible, alleviating suffering and disability when illness does occur, and prolonging…
Measuring the Benefits of Medicines: The Future Agenda
1 March 1990
These papers were presented to an Office of Health Economics meeting in London in October 1989. The programme for the meeting was put together by a…